The retrospective exploration for the new type of medicines for congestive heart failure

The retrospective exploration for the new type of medicines for congestive heart failure - The retrospective exploration for the new type of medicines for congestive heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042693

Enrollment

Registered

2020-12-31

Start date

2020-12-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congestive heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The patients who are treated with Ivabrazin, Dapagliflozin, Sacubitril valsartan sodium hydrate 2. The patients with examination with blood test and echocardiography

Exclusion criteria

Exclusion criteria: Discontinuation

Design outcomes

Primary

Measure	Time frame
The echocardiographic indices	—

Countries

Japan

Contacts

Public ContactNoriaki Iwahashi

Yokohama City University Medical Center Division of Cardiology

niwahash@yokohama-cu.ac.jp045-261-5656

Outcome results